Scholars@Duke

Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank

Publication ,  Conference
Guggenheim, DS; Kurtzberg, J; Shaz, B
Published in: Stem Cells Translational Medicine
September 6, 2022
Published version (DOI) Publisher Link

Duke Scholars

Joanne Kurtzberg
Author Joanne Kurtzberg Pediatrics, Transplant and Cellular Therapy
Beth H. Shaz
Author Beth H. Shaz Pathology

Published In

Stem Cells Translational Medicine

DOI

10.1093/stcltm/szac057.027

EISSN

2157-6580

ISSN

2157-6564

Publication Date

September 6, 2022

Volume

11

Issue

Supplement_1

Start / End Page

S32 / S32

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 4003 Biomedical engineering
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guggenheim, D. S., Kurtzberg, J., & Shaz, B. (2022). Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank. In Stem Cells Translational Medicine (Vol. 11, pp. S32–S32). Oxford University Press (OUP). https://doi.org/10.1093/stcltm/szac057.027
Guggenheim, Dana S., Joanne Kurtzberg, and Beth Shaz. “Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank.” In Stem Cells Translational Medicine, 11:S32–S32. Oxford University Press (OUP), 2022. https://doi.org/10.1093/stcltm/szac057.027.
Guggenheim DS, Kurtzberg J, Shaz B. Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank. In: Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S32–S32.
Guggenheim, Dana S., et al. “Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank.” Stem Cells Translational Medicine, vol. 11, no. Supplement_1, Oxford University Press (OUP), 2022, pp. S32–S32. Crossref, doi:10.1093/stcltm/szac057.027.
Guggenheim DS, Kurtzberg J, Shaz B. Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank. Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S32–S32.

Published In

Stem Cells Translational Medicine

DOI

10.1093/stcltm/szac057.027

EISSN

2157-6580

ISSN

2157-6564

Publication Date

September 6, 2022

Volume

11

Issue

Supplement_1

Start / End Page

S32 / S32

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 4003 Biomedical engineering
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology